<billStatus>
 <version>
  3.0.0
 </version>
 <bill>
  <number>
   2366
  </number>
  <updateDate>
   2023-01-11T13:48:53Z
  </updateDate>
  <updateDateIncludingText>
   2023-01-11T13:48:53Z
  </updateDateIncludingText>
  <originChamber>
   House
  </originChamber>
  <type>
   HR
  </type>
  <introducedDate>
   2021-04-05
  </introducedDate>
  <congress>
   117
  </congress>
  <constitutionalAuthorityStatementText>
   &lt;pre&gt;[Congressional Record Volume 167, Number 60 (Monday, April 5, 2021)][House]From the Congressional Record Online through the Government Publishing Office [&lt;a href="https://www.gpo.gov"&gt;www.gpo.gov&lt;/a&gt;]By Ms. KUSTER:H.R. 2366.Congress has the power to enact this legislation pursuantto the following:Article I, Section VIII: [The Congress shall have Power . .. ] To make all Laws which shall be necessary and proper forcarrying into Execution the foregoing Powers, and all otherPowers vested by this Constitution in the Government of theUnited States, or in any Department or Officer thereof.[Page H1713]&lt;/pre&gt;
  </constitutionalAuthorityStatementText>
  <committees>
   <item>
    <systemCode>
     hsju00
    </systemCode>
    <name>
     Judiciary Committee
    </name>
    <chamber>
     House
    </chamber>
    <type>
     Standing
    </type>
    <subcommittees>
     <item>
      <systemCode>
       hsju08
      </systemCode>
      <name>
       Crime and Federal Government Surveillance Subcommittee
      </name>
      <activities>
       <item>
        <name>
         Referred to
        </name>
        <date>
         2021-10-19T20:38:59Z
        </date>
       </item>
      </activities>
     </item>
    </subcommittees>
    <activities>
     <item>
      <name>
       Referred to
      </name>
      <date>
       2021-04-05T16:03:00Z
      </date>
     </item>
    </activities>
   </item>
   <item>
    <systemCode>
     hsif00
    </systemCode>
    <name>
     Energy and Commerce Committee
    </name>
    <chamber>
     House
    </chamber>
    <type>
     Standing
    </type>
    <subcommittees>
     <item>
      <systemCode>
       hsif14
      </systemCode>
      <name>
       Health Subcommittee
      </name>
      <activities>
       <item>
        <name>
         Referred to
        </name>
        <date>
         2021-04-13T22:57:25Z
        </date>
       </item>
      </activities>
     </item>
    </subcommittees>
    <activities>
     <item>
      <name>
       Referred to
      </name>
      <date>
       2021-04-05T16:02:50Z
      </date>
     </item>
    </activities>
   </item>
  </committees>
  <relatedBills>
   <item>
    <title>
     STOP Fentanyl Act of 2021
    </title>
    <congress>
     117
    </congress>
    <number>
     1457
    </number>
    <type>
     S
    </type>
    <latestAction>
     <actionDate>
      2021-04-29
     </actionDate>
     <text>
      Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
     </text>
    </latestAction>
    <relationshipDetails>
     <item>
      <type>
       Related bill
      </type>
      <identifiedBy>
       CRS
      </identifiedBy>
     </item>
    </relationshipDetails>
   </item>
  </relatedBills>
  <actions>
   <item>
    <actionDate>
     2021-10-19
    </actionDate>
    <committees>
     <item>
      <systemCode>
       hsju08
      </systemCode>
      <name>
       Crime and Federal Government Surveillance Subcommittee
      </name>
     </item>
    </committees>
    <sourceSystem>
     <code>
      1
     </code>
     <name>
      House committee actions
     </name>
    </sourceSystem>
    <text>
     Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
    </text>
    <type>
     Committee
    </type>
   </item>
   <item>
    <actionDate>
     2021-04-13
    </actionDate>
    <committees>
     <item>
      <systemCode>
       hsif14
      </systemCode>
      <name>
       Health Subcommittee
      </name>
     </item>
    </committees>
    <sourceSystem>
     <code>
      1
     </code>
     <name>
      House committee actions
     </name>
    </sourceSystem>
    <text>
     Referred to the Subcommittee on Health.
    </text>
    <type>
     Committee
    </type>
   </item>
   <item>
    <actionDate>
     2021-04-05
    </actionDate>
    <text>
     Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     H11100
    </actionCode>
    <sourceSystem>
     <code>
      2
     </code>
     <name>
      House floor actions
     </name>
    </sourceSystem>
    <committees>
     <item>
      <systemCode>
       hsju00
      </systemCode>
      <name>
       Judiciary Committee
      </name>
     </item>
    </committees>
   </item>
   <item>
    <actionDate>
     2021-04-05
    </actionDate>
    <text>
     Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     H11100
    </actionCode>
    <sourceSystem>
     <code>
      2
     </code>
     <name>
      House floor actions
     </name>
    </sourceSystem>
    <committees>
     <item>
      <systemCode>
       hsif00
      </systemCode>
      <name>
       Energy and Commerce Committee
      </name>
     </item>
    </committees>
   </item>
   <item>
    <actionDate>
     2021-04-05
    </actionDate>
    <text>
     Introduced in House
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     Intro-H
    </actionCode>
    <sourceSystem>
     <code>
      9
     </code>
     <name>
      Library of Congress
     </name>
    </sourceSystem>
   </item>
   <item>
    <actionDate>
     2021-04-05
    </actionDate>
    <text>
     Introduced in House
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     1000
    </actionCode>
    <sourceSystem>
     <code>
      9
     </code>
     <name>
      Library of Congress
     </name>
    </sourceSystem>
   </item>
  </actions>
  <sponsors>
   <item>
    <bioguideId>
     K000382
    </bioguideId>
    <fullName>
     Rep. Kuster, Ann M. [D-NH-2]
    </fullName>
    <firstName>
     Ann
    </firstName>
    <lastName>
     Kuster
    </lastName>
    <party>
     D
    </party>
    <state>
     NH
    </state>
    <middleName>
     M.
    </middleName>
    <district>
     2
    </district>
    <isByRequest>
     N
    </isByRequest>
   </item>
  </sponsors>
  <cosponsors>
   <item>
    <bioguideId>
     B001303
    </bioguideId>
    <fullName>
     Rep. Blunt Rochester, Lisa [D-DE-At Large]
    </fullName>
    <firstName>
     Lisa
    </firstName>
    <lastName>
     Blunt Rochester
    </lastName>
    <party>
     D
    </party>
    <state>
     DE
    </state>
    <district>
     0
    </district>
    <sponsorshipDate>
     2021-04-05
    </sponsorshipDate>
    <isOriginalCosponsor>
     True
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     D000610
    </bioguideId>
    <fullName>
     Rep. Deutch, Theodore E. [D-FL-22]
    </fullName>
    <firstName>
     Theodore
    </firstName>
    <lastName>
     Deutch
    </lastName>
    <party>
     D
    </party>
    <state>
     FL
    </state>
    <middleName>
     E.
    </middleName>
    <district>
     22
    </district>
    <sponsorshipDate>
     2021-04-20
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     T000483
    </bioguideId>
    <fullName>
     Rep. Trone, David J. [D-MD-6]
    </fullName>
    <firstName>
     David
    </firstName>
    <lastName>
     Trone
    </lastName>
    <party>
     D
    </party>
    <state>
     MD
    </state>
    <middleName>
     J.
    </middleName>
    <district>
     6
    </district>
    <sponsorshipDate>
     2021-04-30
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     R000577
    </bioguideId>
    <fullName>
     Rep. Ryan, Tim [D-OH-13]
    </fullName>
    <firstName>
     TIM
    </firstName>
    <lastName>
     RYAN
    </lastName>
    <party>
     D
    </party>
    <state>
     OH
    </state>
    <district>
     13
    </district>
    <sponsorshipDate>
     2021-06-01
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     T000469
    </bioguideId>
    <fullName>
     Rep. Tonko, Paul [D-NY-20]
    </fullName>
    <firstName>
     Paul
    </firstName>
    <lastName>
     Tonko
    </lastName>
    <party>
     D
    </party>
    <state>
     NY
    </state>
    <district>
     20
    </district>
    <sponsorshipDate>
     2021-08-31
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     D000631
    </bioguideId>
    <fullName>
     Rep. Dean, Madeleine [D-PA-4]
    </fullName>
    <firstName>
     Madeleine
    </firstName>
    <lastName>
     Dean
    </lastName>
    <party>
     D
    </party>
    <state>
     PA
    </state>
    <district>
     4
    </district>
    <sponsorshipDate>
     2021-09-03
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     B001298
    </bioguideId>
    <fullName>
     Rep. Bacon, Don [R-NE-2]
    </fullName>
    <firstName>
     Don
    </firstName>
    <lastName>
     Bacon
    </lastName>
    <party>
     R
    </party>
    <state>
     NE
    </state>
    <district>
     2
    </district>
    <sponsorshipDate>
     2021-09-24
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     M001206
    </bioguideId>
    <fullName>
     Rep. Morelle, Joseph D. [D-NY-25]
    </fullName>
    <firstName>
     Joseph
    </firstName>
    <lastName>
     Morelle
    </lastName>
    <party>
     D
    </party>
    <state>
     NY
    </state>
    <middleName>
     D.
    </middleName>
    <district>
     25
    </district>
    <sponsorshipDate>
     2021-10-21
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     W000800
    </bioguideId>
    <fullName>
     Rep. Welch, Peter [D-VT-At Large]
    </fullName>
    <firstName>
     Peter
    </firstName>
    <lastName>
     Welch
    </lastName>
    <party>
     D
    </party>
    <state>
     VT
    </state>
    <district>
     0
    </district>
    <sponsorshipDate>
     2021-10-21
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     D000624
    </bioguideId>
    <fullName>
     Rep. Dingell, Debbie [D-MI-12]
    </fullName>
    <firstName>
     Debbie
    </firstName>
    <lastName>
     Dingell
    </lastName>
    <party>
     D
    </party>
    <state>
     MI
    </state>
    <district>
     12
    </district>
    <sponsorshipDate>
     2021-12-07
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     P000613
    </bioguideId>
    <fullName>
     Rep. Panetta, Jimmy [D-CA-20]
    </fullName>
    <firstName>
     Jimmy
    </firstName>
    <lastName>
     Panetta
    </lastName>
    <party>
     D
    </party>
    <state>
     CA
    </state>
    <district>
     20
    </district>
    <sponsorshipDate>
     2021-12-07
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     P000616
    </bioguideId>
    <fullName>
     Rep. Phillips, Dean [D-MN-3]
    </fullName>
    <firstName>
     Dean
    </firstName>
    <lastName>
     Phillips
    </lastName>
    <party>
     D
    </party>
    <state>
     MN
    </state>
    <district>
     3
    </district>
    <sponsorshipDate>
     2022-07-12
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     L000273
    </bioguideId>
    <fullName>
     Rep. Leger Fernandez, Teresa [D-NM-3]
    </fullName>
    <firstName>
     Teresa
    </firstName>
    <lastName>
     Leger Fernandez
    </lastName>
    <party>
     D
    </party>
    <state>
     NM
    </state>
    <district>
     3
    </district>
    <sponsorshipDate>
     2022-09-02
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
  </cosponsors>
  <policyArea>
   <name>
    Health
   </name>
  </policyArea>
  <subjects>
   <legislativeSubjects>
    <item>
     <name>
      American Samoa
     </name>
    </item>
    <item>
     <name>
      Cardiovascular and respiratory health
     </name>
    </item>
    <item>
     <name>
      Civil actions and liability
     </name>
    </item>
    <item>
     <name>
      Congressional oversight
     </name>
    </item>
    <item>
     <name>
      Corporate finance and management
     </name>
    </item>
    <item>
     <name>
      Correctional facilities and imprisonment
     </name>
    </item>
    <item>
     <name>
      Criminal investigation, prosecution, interrogation
     </name>
    </item>
    <item>
     <name>
      Criminal justice information and records
     </name>
    </item>
    <item>
     <name>
      Criminal procedure and sentencing
     </name>
    </item>
    <item>
     <name>
      Customs enforcement
     </name>
    </item>
    <item>
     <name>
      Drug safety, medical device, and laboratory regulation
     </name>
    </item>
    <item>
     <name>
      Drug therapy
     </name>
    </item>
    <item>
     <name>
      Drug trafficking and controlled substances
     </name>
    </item>
    <item>
     <name>
      Drug, alcohol, tobacco use
     </name>
    </item>
    <item>
     <name>
      Emergency medical services and trauma care
     </name>
    </item>
    <item>
     <name>
      Federal preemption
     </name>
    </item>
    <item>
     <name>
      Government information and archives
     </name>
    </item>
    <item>
     <name>
      Government studies and investigations
     </name>
    </item>
    <item>
     <name>
      HIV/AIDS
     </name>
    </item>
    <item>
     <name>
      Health care costs and insurance
     </name>
    </item>
    <item>
     <name>
      Health care coverage and access
     </name>
    </item>
    <item>
     <name>
      Health information and medical records
     </name>
    </item>
    <item>
     <name>
      Health programs administration and funding
     </name>
    </item>
    <item>
     <name>
      Health promotion and preventive care
     </name>
    </item>
    <item>
     <name>
      Health technology, devices, supplies
     </name>
    </item>
    <item>
     <name>
      Home and outpatient care
     </name>
    </item>
    <item>
     <name>
      Indian social and development programs
     </name>
    </item>
    <item>
     <name>
      Infectious and parasitic diseases
     </name>
    </item>
    <item>
     <name>
      Inflation and prices
     </name>
    </item>
    <item>
     <name>
      Internet and video services
     </name>
    </item>
    <item>
     <name>
      Internet, web applications, social media
     </name>
    </item>
    <item>
     <name>
      Law enforcement administration and funding
     </name>
    </item>
    <item>
     <name>
      Law enforcement officers
     </name>
    </item>
    <item>
     <name>
      Manufacturing
     </name>
    </item>
    <item>
     <name>
      Marketing and advertising
     </name>
    </item>
    <item>
     <name>
      Medical research
     </name>
    </item>
    <item>
     <name>
      Mental health
     </name>
    </item>
    <item>
     <name>
      Minority health
     </name>
    </item>
    <item>
     <name>
      Northern Mariana Islands
     </name>
    </item>
    <item>
     <name>
      Performance measurement
     </name>
    </item>
    <item>
     <name>
      Postal service
     </name>
    </item>
    <item>
     <name>
      Prescription drugs
     </name>
    </item>
    <item>
     <name>
      Research administration and funding
     </name>
    </item>
    <item>
     <name>
      Research and development
     </name>
    </item>
    <item>
     <name>
      Rural conditions and development
     </name>
    </item>
    <item>
     <name>
      Smuggling and trafficking
     </name>
    </item>
    <item>
     <name>
      State and local government operations
     </name>
    </item>
    <item>
     <name>
      Telephone and wireless communication
     </name>
    </item>
    <item>
     <name>
      Trade restrictions
     </name>
    </item>
    <item>
     <name>
      U.S. territories and protectorates
     </name>
    </item>
   </legislativeSubjects>
   <policyArea>
    <name>
     Health
    </name>
   </policyArea>
  </subjects>
  <summaries>
   <summary>
    <versionCode>
     00
    </versionCode>
    <actionDate>
     2021-04-05
    </actionDate>
    <actionDesc>
     Introduced in House
    </actionDesc>
    <updateDate>
     2021-11-03T18:16:54Z
    </updateDate>
    <text>
     &lt;p&gt;&lt;strong&gt;Support, Treatment, and Overdose Prevention of Fentanyl Act of 2021 or the STOP Fentanyl Act of 2021&lt;/strong&gt;&lt;/p&gt; &lt;p&gt;This bill addresses data collection, treatment, harm reduction, and other issues related to substance misuse and addiction. It particularly focuses on opioids, fentanyl, and related substances.&lt;/p&gt; &lt;p&gt;Specifically, the bill expands surveillance of fentanyl and related substances. This includes establishing a pilot program to screen for contaminants in illicit drugs and a grant program to collect data on fentanyl-involved overdoses. The bill also specifies requirements concerning the collection and use of information about drugs seized by law enforcement.&lt;/p&gt; &lt;p&gt;Additionally, the bill establishes and modifies requirements to increase access to treatment and prevention services. For example, the Bureau of Prisons must make certain services, including medication-assisted treatments, available to individuals in its custody. The bill also&lt;/p&gt; &lt;ul&gt; &lt;li&gt;repeals a provision that requires dependence on opioids for at least one year before an individual may be admitted to certain treatment programs;&lt;/li&gt; &lt;li&gt;allows providers to prescribe medications to treat substance use disorders following a telehealth evaluation;&lt;/li&gt; &lt;li&gt;creates grant programs for treatment and harm reduction activities; and&lt;/li&gt; &lt;li&gt;addresses issues pertaining to opioid overdose reversal drugs.&lt;/li&gt; &lt;/ul&gt; &lt;p&gt;Furthermore, the bill limits civil and criminal liability under specified laws for individuals who administer opioid overdose reversal drugs to an individual who reasonably appears to be experiencing an overdose, as well as for individuals who seek medical attention for themselves or on behalf of another for a drug overdose.&lt;/p&gt; &lt;p&gt;The bill also requires multiple reports, including a report by the Department of State on foreign sources of certain drugs.&lt;/p&gt;
    </text>
   </summary>
  </summaries>
  <title>
   STOP Fentanyl Act of 2021
  </title>
  <titles>
   <item>
    <titleType>
     Display Title
    </titleType>
    <title>
     STOP Fentanyl Act of 2021
    </title>
   </item>
   <item>
    <titleType>
     Official Title as Introduced
    </titleType>
    <title>
     To establish programs to address addiction and overdoses caused by illicit fentanyl and other opioids, and for other purposes.
    </title>
    <billTextVersionName>
     Introduced in House
    </billTextVersionName>
    <billTextVersionCode>
     IH
    </billTextVersionCode>
   </item>
   <item>
    <titleType>
     Short Title(s) as Introduced
    </titleType>
    <title>
     STOP Fentanyl Act of 2021
    </title>
    <billTextVersionName>
     Introduced in House
    </billTextVersionName>
    <billTextVersionCode>
     IH
    </billTextVersionCode>
   </item>
   <item>
    <titleType>
     Short Title(s) as Introduced
    </titleType>
    <title>
     Support, Treatment, and Overdose Prevention of Fentanyl Act of 2021
    </title>
    <billTextVersionName>
     Introduced in House
    </billTextVersionName>
    <billTextVersionCode>
     IH
    </billTextVersionCode>
   </item>
  </titles>
  <textVersions>
   <item>
    <type>
     Introduced in House
    </type>
    <date>
     2021-04-05T04:00:00Z
    </date>
    <formats>
     <item>
      <url>
       https://www.govinfo.gov/content/pkg/BILLS-117hr2366ih/xml/BILLS-117hr2366ih.xml
      </url>
     </item>
    </formats>
   </item>
  </textVersions>
  <latestAction>
   <actionDate>
    2021-10-19
   </actionDate>
   <text>
    Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
   </text>
  </latestAction>
 </bill>
 <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
  <dc:format>
   text/xml
  </dc:format>
  <dc:language>
   EN
  </dc:language>
  <dc:rights>
   Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
  </dc:rights>
  <dc:contributor>
   Congressional Research Service, Library of Congress
  </dc:contributor>
  <dc:description>
   This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.
  </dc:description>
 </dublinCore>
</billStatus>

2021-10-19
Crime and Federal Government Surveillance Subcommittee
hsju08
1
House committee actions
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Committee
2021-04-13
Health Subcommittee
hsif14
1
House committee actions
Referred to the Subcommittee on Health.
Committee
H11100
2021-04-05
Judiciary Committee
hsju00
2
House floor actions
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
IntroReferral
H11100
2021-04-05
Energy and Commerce Committee
hsif00
2
House floor actions
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
IntroReferral
Intro-H
2021-04-05
9
Library of Congress
Introduced in House
IntroReferral
1000
2021-04-05
9
Library of Congress
Introduced in House
IntroReferral
2021-04-05T16:03:00Z
Referred to
House
Judiciary Committee
2021-10-19T20:38:59Z
Referred to
Crime and Federal Government Surveillance Subcommittee
hsju08
hsju00
Standing
2021-04-05T16:02:50Z
Referred to
House
Energy and Commerce Committee
2021-04-13T22:57:25Z
Referred to
Health Subcommittee
hsif14
hsif00
Standing
B001303
0
Lisa
Rep. Blunt Rochester, Lisa [D-DE-At Large]
Blunt Rochester
D
2021-04-05
DE
D000610
22
Theodore
Rep. Deutch, Theodore E. [D-FL-22]
Deutch
E.
D
2021-04-20
FL
T000483
6
David
Rep. Trone, David J. [D-MD-6]
Trone
J.
D
2021-04-30
MD
R000577
13
TIM
Rep. Ryan, Tim [D-OH-13]
RYAN
D
2021-06-01
OH
T000469
20
Paul
Rep. Tonko, Paul [D-NY-20]
Tonko
D
2021-08-31
NY
D000631
4
Madeleine
Rep. Dean, Madeleine [D-PA-4]
Dean
D
2021-09-03
PA
B001298
2
Don
Rep. Bacon, Don [R-NE-2]
Bacon
R
2021-09-24
NE
M001206
25
Joseph
Rep. Morelle, Joseph D. [D-NY-25]
Morelle
D.
D
2021-10-21
NY
W000800
0
Peter
Rep. Welch, Peter [D-VT-At Large]
Welch
D
2021-10-21
VT
D000624
12
Debbie
Rep. Dingell, Debbie [D-MI-12]
Dingell
D
2021-12-07
MI
P000613
20
Jimmy
Rep. Panetta, Jimmy [D-CA-20]
Panetta
D
2021-12-07
CA
P000616
3
Dean
Rep. Phillips, Dean [D-MN-3]
Phillips
D
2022-07-12
MN
L000273
3
Teresa
Rep. Leger Fernandez, Teresa [D-NM-3]
Leger Fernandez
D
2022-09-02
NM
Congressional Research Service, Library of Congress
This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
2021-04-05
2021-10-19
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
House
Health
2021-04-29
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
CRS
Related bill
STOP Fentanyl Act of 2021
S
K000382
2
Ann
Rep. Kuster, Ann M. [D-NH-2]
N
Kuster
M.
D
NH
American Samoa Cardiovascular and respiratory health Civil actions and liability Congressional oversight Corporate finance and management Correctional facilities and imprisonment Criminal investigation, prosecution, interrogation Criminal justice information and records Criminal procedure and sentencing Customs enforcement Drug safety, medical device, and laboratory regulation Drug therapy Drug trafficking and controlled substances Drug, alcohol, tobacco use Emergency medical services and trauma care Federal preemption Government information and archives Government studies and investigations HIV/AIDS Health care costs and insurance Health care coverage and access Health information and medical records Health programs administration and funding Health promotion and preventive care Health technology, devices, supplies Home and outpatient care Indian social and development programs Infectious and parasitic diseases Inflation and prices Internet and video services Internet, web applications, social media Law enforcement administration and funding Law enforcement officers Manufacturing Marketing and advertising Medical research Mental health Minority health Northern Mariana Islands Performance measurement Postal service Prescription drugs Research administration and funding Research and development Rural conditions and development Smuggling and trafficking State and local government operations Telephone and wireless communication Trade restrictions U.S. territories and protectorates
2021-04-05
Introduced in House
 <p><strong>Support, Treatment, and Overdose Prevention of Fentanyl Act of 2021 or the STOP Fentanyl Act of 2021</strong></p> <p>This bill addresses data collection, treatment, harm reduction, and other issues related to substance misuse and addiction. It particularly focuses on opioids, fentanyl, and related substances.</p> <p>Specifically, the bill expands surveillance of fentanyl and related substances. This includes establishing a pilot program to screen for contaminants in illicit drugs and a grant program to collect data on fentanyl-involved overdoses. The bill also specifies requirements concerning the collection and use of information about drugs seized by law enforcement.</p> <p>Additionally, the bill establishes and modifies requirements to increase access to treatment and prevention services. For example, the Bureau of Prisons must make certain services, including medication-assisted treatments, available to individuals in its custody. The bill also</p> <ul> <li>repeals a provision that requires dependence on opioids for at least one year before an individual may be admitted to certain treatment programs;</li> <li>allows providers to prescribe medications to treat substance use disorders following a telehealth evaluation;</li> <li>creates grant programs for treatment and harm reduction activities; and</li> <li>addresses issues pertaining to opioid overdose reversal drugs.</li> </ul> <p>Furthermore, the bill limits civil and criminal liability under specified laws for individuals who administer opioid overdose reversal drugs to an individual who reasonably appears to be experiencing an overdose, as well as for individuals who seek medical attention for themselves or on behalf of another for a drug overdose.</p> <p>The bill also requires multiple reports, including a report by the Department of State on foreign sources of certain drugs.</p>
2021-11-03T18:16:54Z
00
2021-04-05T04:00:00Z
Introduced in House
https://www.govinfo.gov/content/pkg/BILLS-117hr2366ih/xml/BILLS-117hr2366ih.xml
STOP Fentanyl Act of 2021
STOP Fentanyl Act of 2021
Display Title
IH
Introduced in House
To establish programs to address addiction and overdoses caused by illicit fentanyl and other opioids, and for other purposes.
Official Title as Introduced
IH
Introduced in House
STOP Fentanyl Act of 2021
Short Title(s) as Introduced
IH
Introduced in House
Support, Treatment, and Overdose Prevention of Fentanyl Act of 2021
Short Title(s) as Introduced
HR
2023-01-11T13:48:53Z
2023-01-11T13:48:53Z
3.0.0
2021-04-29
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
CRS
Related bill
STOP Fentanyl Act of 2021
S
2021-10-19
Crime and Federal Government Surveillance Subcommittee
hsju08
1
House committee actions
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Committee
2021-04-13
Health Subcommittee
hsif14
1
House committee actions
Referred to the Subcommittee on Health.
Committee
H11100
2021-04-05
Judiciary Committee
hsju00
2
House floor actions
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
IntroReferral
H11100
2021-04-05
Energy and Commerce Committee
hsif00
2
House floor actions
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
IntroReferral
Intro-H
2021-04-05
9
Library of Congress
Introduced in House
IntroReferral
1000
2021-04-05
9
Library of Congress
Introduced in House
IntroReferral
K000382
2
Ann
Rep. Kuster, Ann M. [D-NH-2]
N
Kuster
M.
D
NH
B001303
0
Lisa
Rep. Blunt Rochester, Lisa [D-DE-At Large]
Blunt Rochester
D
2021-04-05
DE
D000610
22
Theodore
Rep. Deutch, Theodore E. [D-FL-22]
Deutch
E.
D
2021-04-20
FL
T000483
6
David
Rep. Trone, David J. [D-MD-6]
Trone
J.
D
2021-04-30
MD
R000577
13
TIM
Rep. Ryan, Tim [D-OH-13]
RYAN
D
2021-06-01
OH
T000469
20
Paul
Rep. Tonko, Paul [D-NY-20]
Tonko
D
2021-08-31
NY
D000631
4
Madeleine
Rep. Dean, Madeleine [D-PA-4]
Dean
D
2021-09-03
PA
B001298
2
Don
Rep. Bacon, Don [R-NE-2]
Bacon
R
2021-09-24
NE
M001206
25
Joseph
Rep. Morelle, Joseph D. [D-NY-25]
Morelle
D.
D
2021-10-21
NY
W000800
0
Peter
Rep. Welch, Peter [D-VT-At Large]
Welch
D
2021-10-21
VT
D000624
12
Debbie
Rep. Dingell, Debbie [D-MI-12]
Dingell
D
2021-12-07
MI
P000613
20
Jimmy
Rep. Panetta, Jimmy [D-CA-20]
Panetta
D
2021-12-07
CA
P000616
3
Dean
Rep. Phillips, Dean [D-MN-3]
Phillips
D
2022-07-12
MN
L000273
3
Teresa
Rep. Leger Fernandez, Teresa [D-NM-3]
Leger Fernandez
D
2022-09-02
NM
American Samoa Cardiovascular and respiratory health Civil actions and liability Congressional oversight Corporate finance and management Correctional facilities and imprisonment Criminal investigation, prosecution, interrogation Criminal justice information and records Criminal procedure and sentencing Customs enforcement Drug safety, medical device, and laboratory regulation Drug therapy Drug trafficking and controlled substances Drug, alcohol, tobacco use Emergency medical services and trauma care Federal preemption Government information and archives Government studies and investigations HIV/AIDS Health care costs and insurance Health care coverage and access Health information and medical records Health programs administration and funding Health promotion and preventive care Health technology, devices, supplies Home and outpatient care Indian social and development programs Infectious and parasitic diseases Inflation and prices Internet and video services Internet, web applications, social media Law enforcement administration and funding Law enforcement officers Manufacturing Marketing and advertising Medical research Mental health Minority health Northern Mariana Islands Performance measurement Postal service Prescription drugs Research administration and funding Research and development Rural conditions and development Smuggling and trafficking State and local government operations Telephone and wireless communication Trade restrictions U.S. territories and protectorates
2021-04-05
Introduced in House
 <p><strong>Support, Treatment, and Overdose Prevention of Fentanyl Act of 2021 or the STOP Fentanyl Act of 2021</strong></p> <p>This bill addresses data collection, treatment, harm reduction, and other issues related to substance misuse and addiction. It particularly focuses on opioids, fentanyl, and related substances.</p> <p>Specifically, the bill expands surveillance of fentanyl and related substances. This includes establishing a pilot program to screen for contaminants in illicit drugs and a grant program to collect data on fentanyl-involved overdoses. The bill also specifies requirements concerning the collection and use of information about drugs seized by law enforcement.</p> <p>Additionally, the bill establishes and modifies requirements to increase access to treatment and prevention services. For example, the Bureau of Prisons must make certain services, including medication-assisted treatments, available to individuals in its custody. The bill also</p> <ul> <li>repeals a provision that requires dependence on opioids for at least one year before an individual may be admitted to certain treatment programs;</li> <li>allows providers to prescribe medications to treat substance use disorders following a telehealth evaluation;</li> <li>creates grant programs for treatment and harm reduction activities; and</li> <li>addresses issues pertaining to opioid overdose reversal drugs.</li> </ul> <p>Furthermore, the bill limits civil and criminal liability under specified laws for individuals who administer opioid overdose reversal drugs to an individual who reasonably appears to be experiencing an overdose, as well as for individuals who seek medical attention for themselves or on behalf of another for a drug overdose.</p> <p>The bill also requires multiple reports, including a report by the Department of State on foreign sources of certain drugs.</p>
2021-11-03T18:16:54Z
00
STOP Fentanyl Act of 2021
STOP Fentanyl Act of 2021
Display Title
IH
Introduced in House
To establish programs to address addiction and overdoses caused by illicit fentanyl and other opioids, and for other purposes.
Official Title as Introduced
IH
Introduced in House
STOP Fentanyl Act of 2021
Short Title(s) as Introduced
IH
Introduced in House
Support, Treatment, and Overdose Prevention of Fentanyl Act of 2021
Short Title(s) as Introduced
2021-10-19
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.